Claritas Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
Claritas Pharmaceuticals has raised $5.0M across 1 funding round on record, the most recent a Private Equity of $5.0M announced in Jan 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Claritas Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Claritas Pharmaceuticals Funding Rounds
Claritas Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Claritas Pharmaceuticals Funding Compared to Other Biotechnology Startups
Claritas Pharmaceuticals' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Claritas Pharmaceuticals in Biotechnology and San Rafael
Companies Similar to Claritas Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Claritas Pharmaceuticals Funding FAQs
What does Claritas Pharmaceuticals do?
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
How much funding has Claritas Pharmaceuticals raised?
Claritas Pharmaceuticals has raised $5.0M across 1 round on record. The most recent is a Private Equity of $5.0M announced in Jan 2022.
When did Claritas Pharmaceuticals last raise funding?
Claritas Pharmaceuticals' most recent funding round on record is a Private Equity of $5.0M, announced in Jan 2022.
Who is the CEO of Claritas Pharmaceuticals?
Bob Farrell is listed as CEO at Claritas Pharmaceuticals.
Where is Claritas Pharmaceuticals headquartered?
Claritas Pharmaceuticals is based in San Rafael, California, United States.
How many employees does Claritas Pharmaceuticals have?
Claritas Pharmaceuticals is in the 11-50 employee band.
How does Claritas Pharmaceuticals' funding compare to other Biotechnology startups?
Claritas Pharmaceuticals' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Claritas Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Claritas Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.